Prognostic evaluation of plasma nt-probnp levels both before and after beta-blocker therapy in chronic congestive heart failure
- At: 2007 FIP Congress in Beijing (China)
- Type: Poster
- By: LI, Na (Fuwai Hospital, CAMS, PUMC, Beijing, China)
- Co-author(s): Wang, Fang (Fuwai Hospital, CAMS, PUMC, BEIJING, China)
Hua, Congxiao (Fuwai Hospital, CAMS, PUMC, BEIJING, China)
Li, Yishi (Fuwai Hospital, CAMS, PUMC, BEIJING, China)
Purpose Beta-blockers exert complex effects on plasma N-terminal-pro-B-type natriuretic peptide (NT-proBNP) level. We aimed to investigate whether NT-proBNP was still able to predict the prognosis of the disease after administration of a beta-blocker. Methods Forty-four patients with chronic congestive heart failure were enrolled in the study to.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.